Fmr LLC raised its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 3.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,311,867 shares of the company’s stock after purchasing an additional 546,869 shares during the period. Fmr LLC owned 0.14% of Surgery Partners worth $590,375,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. KBC Group NV increased its position in Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after purchasing an additional 576 shares during the last quarter. DekaBank Deutsche Girozentrale increased its position in Surgery Partners by 102.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after purchasing an additional 1,375 shares during the last quarter. Quarry LP increased its position in Surgery Partners by 133.1% during the second quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after purchasing an additional 1,760 shares during the last quarter. Creative Planning acquired a new position in Surgery Partners during the third quarter worth approximately $258,000. Finally, Versor Investments LP acquired a new position in Surgery Partners during the third quarter worth approximately $271,000.
Surgery Partners Trading Up 2.3 %
Surgery Partners stock opened at $23.41 on Friday. The firm’s 50-day moving average is $29.15 and its 200-day moving average is $28.24. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. Surgery Partners, Inc. has a 1 year low of $21.36 and a 1 year high of $36.92. The company has a market cap of $2.98 billion, a P/E ratio of -48.77, a PEG ratio of 19.47 and a beta of 2.76.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on the stock. StockNews.com lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. Cantor Fitzgerald reissued an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a research report on Friday, October 4th. Royal Bank of Canada dropped their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday, November 20th. Citigroup dropped their price objective on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Finally, KeyCorp assumed coverage on shares of Surgery Partners in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $38.71.
Get Our Latest Analysis on SGRY
Surgery Partners Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Read More
- Five stocks we like better than Surgery Partners
- How to Calculate Inflation Rate
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is the FTSE 100 index?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Why Are Stock Sectors Important to Successful Investing?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY – Free Report).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.